Core Insights - The company, Yuejiang (02432HK), has made significant advancements in the field of embodied intelligence, becoming the first globally to launch a comprehensive robotic platform that integrates "robotic arms, humanoids, and multi-legged robots" [1][3] - Despite facing a complex macroeconomic environment and uncertainties related to tariffs and trade policies, the company reported impressive performance for the first half of 2025, with revenue reaching 153 million RMB, a year-on-year increase of 27.1%, significantly higher than the 9.6% growth rate in the same period of 2024 [1][3] Financial Performance - The company's revenue for the first half of 2025 was 153 million RMB, reflecting a 27.1% increase compared to the previous year [1][3] - Domestic revenue saw a substantial growth of 56.7%, with six-axis revenue accounting for 61% of total revenue [1] - The gross margin improved from 43.9% in the same period of 2024 to 47% [3] - The net loss was reported at 40.9 million RMB, a reduction of 31.8% compared to the previous year, while the adjusted net loss was 22.9 million RMB, down 34.4% year-on-year [3] Market Expansion - The company has leveraged its full-stack self-research capabilities and diverse product matrix, with applications across various sectors including industrial manufacturing, commercial retail, medical surgery, health therapy, and educational research [3] - Yuejiang's products are now utilized in over 100 countries and regions worldwide, indicating a strong global presence [3]